These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 9766719

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
    Katsoulis IE, Wong WL, Mattheou AK, Damani N, Chambers J, Livingstone JI.
    Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Positron emission tomography for the preoperative staging of esophageal carcinoma].
    Junginger T, Kneist W, Schreckenberger M, Menzel C, Oberholzer K, Bartenstein P.
    Dtsch Med Wochenschr; 2002 Sep 20; 127(38):1935-41. PubMed ID: 12239652
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
    Meltzer CC, Luketich JD, Friedman D, Charron M, Strollo D, Meehan M, Urso GK, Dachille MA, Townsend DW.
    Clin Nucl Med; 2000 Nov 20; 25(11):882-7. PubMed ID: 11079584
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Improvement in staging of esophageal cancer with the addition of positron emission tomography.
    Block MI, Patterson GA, Sundaresan RS, Bailey MS, Flanagan FL, Dehdashti F, Siegel BA, Cooper JD.
    Ann Thorac Surg; 1997 Sep 20; 64(3):770-6; discussion 776-7. PubMed ID: 9307472
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
    Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, Dupont P, Bormans G, Hiele M, De Leyn P, Van Raemdonck D, Coosemans W, Ectors N, Haustermans K, Mortelmans L.
    J Clin Oncol; 2000 Sep 15; 18(18):3202-10. PubMed ID: 10986052
    [Abstract] [Full Text] [Related]

  • 17. Metabolic information on staging FDG-PET-CT as a prognostic tool in the evaluation of 97 patients with gastric cancer.
    Coupe NA, Karikios D, Chong S, Yap J, Ng W, Merrett N, Lin M.
    Ann Nucl Med; 2014 Feb 15; 28(2):128-35. PubMed ID: 24297388
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study.
    Yoon YC, Lee KS, Shim YM, Kim BT, Kim K, Kim TS.
    Radiology; 2003 Jun 15; 227(3):764-70. PubMed ID: 12773680
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.